Misoprostol brand

Misoprostol brand

Lists the various brand names available for medicines containing misoprostol. Find information on misoprostol use, treatment, drug class and molecular formula. The Complete Mifepristone and Misoprostol Handbook: An Evidence-Based Guide to Pharmacology, Clinical Applications, Safety, Patient Care, and Current Best Practices CYTOTEC® (misoprostol) medication page for healthcare professionals to search for scientific information on Pfizer medications. Also find the prescribing information, announcements, resources, and channels to connect with Pfizer Medical This product information is intended only for residents of the United States. Misoprostol (Cytotec) is a prescription medication that's FDA approved to lower the risk of stomach ulcers in certain people who take nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen. Misoprostol was FDA approved on December 27, 1988, under the brand Cytotec. Generic misoprostol is available. Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Misoprostol may cause serious side effects. Call your doctor at once if you have: How is misoprostol supplied (dosage forms)? Misoprostol is available as Cytotec and generic misoprostol in the following dosage forms that are taken by mouth. It is available as a generic medication. [10] Misoprostol is used for the prevention of NSAID -induced gastric ulcers. Cytotec (Misoprostol) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. Misoprostol is used to decrease the risk of having stomach ulcers in patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) including aspirin. This medicine works by helping the stomach protect itself against acid damage, and decreases the amount of acid produced by the stomach.

Leave a Reply

Your email address will not be published. Required fields are marked *

*
*